You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Baseline description of 382 women initiating ART during pregnancy, by delay in days from screening to ART initiation

From: Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study

  Not initiating ART during antenatal period Total initiating ART during antenatal period Delay from screening to ART initiation during antenatal period p-value
    <14 days 14-20 days 21-27 days 28-34 days 35+ days  
Number of patients 108 382 54 136 61 66 65 --
Median age (IQR) 26 (23–31) 27 (24–31) 29 (24–32) 27 (24–31) 28 (25–32) 27 (25–31) 27 (25–31) 0.965
Median gestation (IQR) 31 (27–34) 27 (23–31) 32 (28–34) 28 (26–32) 27 (23–30) 24 (20–28) 21 (17–25) <0.001
  <24 weeks 12 (12) 104 (27) 3 (6) 14 (10) 16 (26) 30 (45) 41 (63) <0.001
  24-28 weeks 25 (24) 134 (35) 12 (22) 57 (42) 26 (43) 21 (32) 18 (28)  
  29-32 weeks 33 (31) 94 (25) 19 (35) 40 (29) 14 (23) 15 (23) 6 (9)  
  >32 weeks 34 (33) 50 (13) 20 (37) 25 (18) 5 (8) 0 0  
WHO stage:  I 67 (62) 206 (55) 25 (48) 83 (62) 38 (62) 34 (52) 26 (40) 0.003
      II 17 (16) 69 (18) 7 (13) 29 (22) 10 (16) 13 (20) 10 (15)  
      III 22 (20) 90 (24) 17 (33) 18 (13) 13 (21) 15 (23) 27 (42)  
      IV 2 (2) 13 (3) 3 (6) 4 (3) 0 4 (6) 2 (3)  
Median CD4 cell count (IQR) * 120 (65–166) 142 (96–186) 139 (85–187) 143 (96–186) 153 (112–210) 133 (104–170) 134 (94–172) 0.538
  CD4 <100 cells/μl 9 (39) 99 (28) 19 (36) 38 (29) 11 (19) 15 (24) 16 (29)  
Median HIV Viral load (IQR) * 4.9 (4.6-4.9) 4.3 (3.7-4.8) 4.2 (3.4-4.8) 4.2 (3.8-4.8) 4.4 (3.9-4.9) 4.5 (3.9-4.9) 4.6 (4.1-4.8) 0.211
  >5 log10 copies/mL 3 (15) 55 (15) 9 (17) 17 (13) 8 (14) 13 (21) 8 (15)  
  1. * For the 108 women not starting ART, CD4 data were available on 23 patients (21%) and viral load data were available on 22 patients (20%); for the 382 women starting ART, CD4 data were available on 357 patients (93%) and viral load data were available on 358 patients (94%).